期刊文献+

N链接聚糖,癌症诊断的标志物(英文)

N-glycan,a biomarker in current cancer diagnosis
下载PDF
导出
摘要 蛋白质糖基化是一种最常见也是最复杂的蛋白质翻译后修饰过程,是指蛋白质或脂质附加上聚糖的过程。糖蛋白的聚糖部分的重要功能之一是维持多细胞生物体细胞的稳态。糖基化过程在外界生物化学环境的影响下会发生改变,包括生理条件的改变和某些特殊疾病状况例如癌症,从而导致糖链结构的改变。目前由于传统癌症标志物灵敏度和特异度较低,导致癌症不能在疾病早期阶段被识别,寻找新的癌症诊断标志物成为癌症研究的重要方向之一。近年来,糖基组学技术的进步为深入分析糖链结构提供了有力条件。因此,寻找合适的糖基作为癌症诊断的新的标志物成为癌症研究的热点。本篇综述阐释了聚糖作为癌症诊断标志物这一研究方向的进展状况。 Glycosylation, links the glycan chains to protein or lipid, is the most common and complex post-translational modifications of proteins. One of the important functions of glycans is to maintain the ordered social life of each cell in multi-cellular organisms. Glycosylation is sensitive to the biochemical environment leading to the alternation of glycan chains under physiological condition and specific diseases such as cancer. Up to date, cancer and other lethal diseases could not be diagnosed at early stage because of the traditional marker's low sensitivity and less specificity. Recent years, the development of glycan profiling technologies has offered technology support for understanding the complex glycan structures and has increased great interest in applying the technology for cancer studies. In this regard, to identify the glycans as the potential biomarkers of cancer has become an important direction for clinical cancer diagnosis. This review summarizes the current research on finding the glycans as new cancer biomarkers.
出处 《转化医学研究(电子版)》 2012年第1期70-76,共7页 Translational Medicine Research(Electronic Edition)
关键词 N链接聚糖 寡糖 癌症 生物标志物 N-glycan oligosaccharide cancer biomarker
  • 相关文献

参考文献1

二级参考文献18

  • 1中华医学会检验医学分会肿瘤标志物专家委员会.肿瘤标志物检测临床应用的基本原则(讨论稿)[J].中华检验医学杂志,2004,:27-27.
  • 2王健 吉强 殷建华 等.AFP实验室检测40年[A]..肿瘤标志专题讨论会论文集[C].,2002.27-35.
  • 3Pritzker KH. Cancer biomarkers : easier said than done. Clin Chem, 2002,48: 1147- 1150.
  • 4Fleisher M, Dnistrian AM, Sturgeon CM, et al. Practice guidelines and recommendations for use tumor markers in the clinic. Washington DC: AACC Press,2002.20-25
  • 5Lichtenstein AV, Potapova GI. Genetic defects as tumor markers. Molecular Biol, 2003,37:159-169.
  • 6Lakhani SR, Ashworth A. Microarray and histo-pathological analysis of tumours:the future and the past? Nature Rev Cancer, 2001,1:151-157.
  • 7Yu H, Diamandis EP, Levesque M, et al. Prostate specific antigen in breast cancer benign breast disease and normal breast tissue. Breast Cancer Res Treat, 1996,40:171- 178.
  • 8Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer, 2003,3:267-275.
  • 9Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer, 2002, 2:210-219.
  • 10Sun X, Hung K, Wu L, et al. Detection of tumor mutations in the presence of excess amounts of normal DNA. Nat Biotechol, 2002,20:186-189.

共引文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部